BCN-DOTA-GA
Product Specifications
UNSPSC Description
BCN-DOTA-GA is a cyclooctyne-linked DOTA chelator that can be labeled with radioactive zirconium-89 and used as a radionuclide-labeled drug conjugate (RDC) to target specific biomolecules, cells or tissues.
Target Antigen
Radionuclide-Drug Conjugates (RDCs)
Type
Reference compound
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
cancer
Assay Protocol
https://www.medchemexpress.com/bcn-dota-ga.html
Smiles
O=C(NCCNC(OC[C@H]1[C@@]2([H])CCC#CCC[C@@]12[H])=O)CCC(N3CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC3)C(O)=O
Molecular Weight
694.77
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-164577/BCN-DOTA-GA-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-164577/
Clinical Information
No Development Reported
CAS Number
2416980-98-6
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
